Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Divestments (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Divestments for 6 consecutive years, with $15000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Divestments fell 99.27% to $15000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $2.0 million, a 19.3% decrease, with the full-year FY2024 number at $4.3 million, up 2515.34% from a year prior.
  • Divestments was $15000.0 for Q2 2025 at Select Medical Holdings, down from $24000.0 in the prior quarter.
  • In the past five years, Divestments ranged from a high of $15.6 million in Q4 2021 to a low of $4000.0 in Q3 2023.
  • A 4-year average of $2.2 million and a median of $69500.0 in 2023 define the central range for Divestments.
  • Peak YoY movement for Divestments: crashed 99.83% in 2021, then skyrocketed 47600.0% in 2024.
  • Select Medical Holdings' Divestments stood at $15.6 million in 2021, then plummeted by 99.34% to $103000.0 in 2023, then plummeted by 78.64% to $22000.0 in 2024, then tumbled by 31.82% to $15000.0 in 2025.
  • Per Business Quant, the three most recent readings for SEM's Divestments are $15000.0 (Q2 2025), $24000.0 (Q1 2025), and $22000.0 (Q4 2024).